There were 1,535 press releases posted in the last 24 hours and 440,951 in the last 365 days.

Update to RSV Prevention Program - Abrysvo™ Available for Adults 60+ and Pregnant Individuals

This memo follows our September 29th, 2025 communication regarding the RSV Prevention Program, in which Hamilton Public Health advised that for those that meet the required eligibility, Arexvy be used for older adults 60+ and that Abrysvo™ be reserved for pregnant individuals.

We are pleased to inform you that the Ministry has advised us that Abrysvo™ is now available for use in both older adults aged 60+ as well as pregnant individuals.

When placing an order, please note that if you select Arexv, we will fulfil your request based on the doses currently available in our vaccine inventory. If we do not have sufficient supply of Arexvy to fulfil your order, you will be provided with Abrysvo™.

As a reminder, if an individual has previously received a dose of RSV vaccine, they do not need to receive another dose this season, as booster doses are not currently recommended.

To place an order, please complete the attached order form and submit by email to [email protected] or by fax to 905-546-3472.

When ordering, please allow 24-48 hours for processing and ensure that you attach 4 weeks of refrigerator temperatures.

Update to Abrysvo and Arexvy for Adults 60+ and Pregnant Individuals for the 2025-2026 RSV Prevention Program - Nov 13, 2025(PDF, 175.84 KB)

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.